145 filings
Page 3 of 8
8-K
gjf8is 4gock2u
4 Dec 20
Other Events
12:30pm
8-K
xu6bksrye91 komhwh
9 Nov 20
Zynerba Pharmaceuticals Reports Third Quarter 2020 Financial Results
7:16am
8-K
bldw8zlexhekovh
15 Oct 20
Other Events
4:15pm
8-K
dubo onbte259ck
17 Sep 20
Zynerba Pharmaceuticals Receives Orphan Drug Designation for Cannabidiol for the Treatment of 22q11.2 Deletion Syndrome
4:05pm
8-K
a0r17ha 1u
14 Sep 20
Zynerba Pharmaceuticals Provides Update on Recent Milestones
7:01am
8-K
dl74ngmyurqpymb4
10 Aug 20
Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results
6:45am
8-K
w3s0q
22 Jul 20
Zynerba Pharmaceuticals to Present an Update on the Zygel™ Development Program at the 17th NFXF International Fragile X Conference Research Roundup
7:00am
8-K
1xfbj xwzk
30 Jun 20
Zynerba Pharmaceuticals Announces Top Line Results from Pivotal CONNECT-FX Trial of Zygel™ (CBD Gel) in Fragile X Syndrome
6:50am
8-K
mv6 8spr8owgsv2d2xvn
11 Jun 20
Submission of Matters to a Vote of Security Holders
4:10pm
8-K/A
0b0 oq5pcpl2
2 Jun 20
Other Events
4:12pm
8-K
lwlqrc3
2 Jun 20
Other Events
7:30am
8-K
gcnx sc0js5
27 May 20
Zynerba Pharmaceuticals Announces Positive Top Line Results from Exploratory Open Label Phase 2 BRIGHT Trial of Zygel in Autism Spectrum Disorder
7:10am
8-K
hd6bwp2c5y4 mjhn9
26 May 20
Other Events
7:15am
8-K
h0ui gox91
11 May 20
Zynerba Pharmaceuticals Reports First Quarter 2020 Financial Results
7:00am
8-K
2czx1 6mo12
15 Apr 20
Other Events
7:30am
8-K
f6ofd9f79ygifc
10 Mar 20
Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2019 Financial Results and Operational Highlights
7:16am
8-K
ymgtsmj
3 Mar 20
Zynerba Pharmaceuticals Presents Health State Utility Index Data on Severity of Fragile X Syndrome (FXS) and Diagnostic Challenges Faced by Caregivers
12:15pm
8-K
tpj3wrno
26 Feb 20
Zynerba Pharmaceuticals Announces the Completion of Enrollment in the Pivotal CONNECT-FX Trial of Zygel™ in Fragile X Syndrome
7:00am
8-K
kclmkl83i9wffzg
25 Feb 20
Zynerba Pharmaceuticals Receives New U.S. Patent for Treatment of Autism Spectrum Disorder with Purified Cannabidiol
7:31am
8-K
8gi4yqj5h3 fk008r
3 Feb 20
Zynerba Pharmaceuticals Announces Achievement of Patient Screening Target
7:00am